PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-0.02%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$6.86B
AUM Growth
+$6.86B
(-11%)
Cap. Flow
-$337M
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
44.38%
Holding
171
New
21
Increased
19
Reduced
29
Closed
31
Top Buys
| 1 |
Procept Biorobotics
PRCT
|
$63.2M |
| 2 |
ICVX
Icosavax, Inc. Common Stock
ICVX
|
$56.9M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$46.9M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$35.7M |
| 5 |
Amicus Therapeutics
FOLD
|
$32.8M |
Top Sells
| 1 |
United Therapeutics
UTHR
|
$87.7M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$65M |
| 3 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$60.8M |
| 4 |
Medtronic
MDT
|
$55.9M |
| 5 |
Astria Therapeutics
ATXS
|
$50.6M |
Sector Composition
| 1 | Healthcare | 84.69% |
| 2 | Financials | 0.36% |
| 3 | Industrials | 0.17% |
| 4 | Consumer Discretionary | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Xenon Pharmaceuticals
XENE
$3.01B
| $30.9M | 0.45% |
2,022,051
+343,078
| +20% | +$5.24M |
|
|
NVRO
52
DELISTED
NEVRO CORP.
NVRO
| $30.3M | 0.44% |
259,972
-558,788
| -68% | -$65M |
|
53
Nuvation Bio
NUVB
$1.05B
| $30.2M | 0.44% |
3,041,004
| – | – |
|
54
Health Catalyst
HCAT
$227M
| $29.5M | 0.43% |
589,004
+22,920
| +4% | +$1.15M |
|
55
Lyra Therapeutics
LYRA
$11.8M
| $29.4M | 0.43% |
3,222,560
| – | – |
|
56
Tarsus Pharmaceuticals
TARS
$2.42B
| $27.9M | 0.41% |
1,296,416
| – | – |
|
57
Cogent Biosciences
COGT
$1.8B
| $26.8M | 0.39% |
3,188,750
| – | – |
|
|
58
United Therapeutics
UTHR
$18B
| $26.2M | 0.38% |
141,700
-475,102
| -77% | -$87.7M |
|
|
SLGC
59
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $25.4M | 0.37% |
+2,050,000
| New | +$25.4M |
|
60
BioAtla
BCAB
$28.2M
| $25M | 0.36% |
850,026
+164,507
| +24% | +$4.84M |
|
61
Viridian Therapeutics
VRDN
$1.57B
| $23.4M | 0.34% |
1,423,000
+628,494
| +79% | +$10.3M |
|
62
Avidity Biosciences
RNA
$6.04B
| $21.8M | 0.32% |
885,818
-193,210
| -18% | -$4.76M |
|
63
Celldex Therapeutics
CLDX
$1.57B
| $21.3M | 0.31% |
393,613
-349,086
| -47% | -$18.8M |
|
64
Apellis Pharmaceuticals
APLS
$3.5B
| $20.3M | 0.29% |
615,000
-46,162
| -7% | -$1.52M |
|
65
GeneDx Holdings
WGS
$3.65B
| $19M | 0.28% |
2,500,000
+2,273,000
| +1,001% | +$17.3M |
|
66
Harmony Biosciences
HRMY
$2.14B
| $18.8M | 0.27% |
491,332
| – | – |
|
|
HLTH
67
DELISTED
Cue Health Inc. Common Stock
HLTH
| $18.7M | 0.27% |
+1,580,607
| New | +$18.7M |
|
68
Immuneering
IMRX
$225M
| $18.1M | 0.26% |
+681,051
| New | +$18.1M |
|
69
Natera
NTRA
$22.8B
| $17.8M | 0.26% |
+160,000
| New | +$17.8M |
|
70
Tyra Biosciences
TYRA
$668M
| $17.4M | 0.25% |
+987,500
| New | +$17.4M |
|
|
71
Astria Therapeutics
ATXS
$387M
| $17.3M | 0.25% |
1,959,652
-5,727,533
| -75% | -$50.6M |
|
72
Absci
ABSI
$350M
| $17.2M | 0.25% |
+1,476,776
| New | +$17.2M |
|
73
Nuvalent
NUVL
$5.66B
| $16.9M | 0.25% |
+750,000
| New | +$16.9M |
|
|
VRNA
74
Verona Pharma
VRNA
$9.18B
| $15.8M | 0.23% |
2,888,889
| – | – |
|
|
AGRX
75
DELISTED
Agile Therapeutics, Inc
AGRX
| $15.3M | 0.22% |
15,919,925
| – | – |
|